Neurogenic Orthostatic Hypotension clinical trials

Explore recruiting neurogenic orthostatic hypotension clinical trials.

Recruiting neurogenic orthostatic hypotension studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurogenic Orthostatic Hypotension trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of efficacy and tolerance of fludrocortisone (Flucortac) in the treatment of neurogenic orthostatic hypotension

France

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multi-center, Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy

Denmark, Spain, Austria, France, Germany, Italy +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurogenic Orthostatic Hypotension trials by city

Neurogenic Orthostatic Hypotension in Toronto Neurogenic Orthostatic Hypotension in Vancouver Neurogenic Orthostatic Hypotension in Montreal Neurogenic Orthostatic Hypotension in Calgary Neurogenic Orthostatic Hypotension in Edmonton Neurogenic Orthostatic Hypotension in Ottawa Neurogenic Orthostatic Hypotension in Winnipeg Neurogenic Orthostatic Hypotension in Quebec City Neurogenic Orthostatic Hypotension in Hamilton Neurogenic Orthostatic Hypotension in Kitchener Neurogenic Orthostatic Hypotension in London Neurogenic Orthostatic Hypotension in Halifax Neurogenic Orthostatic Hypotension in New York Neurogenic Orthostatic Hypotension in Los Angeles Neurogenic Orthostatic Hypotension in Chicago Neurogenic Orthostatic Hypotension in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease